Adjuvant Therapy

Adjuvant therapy is treatment that comes alongside or after the main treatment for cancer, most often after surgery has removed a visible tumor. The word adjuvant comes from the Latin for to help, and that captures its purpose: it is the helper treatment that works to clean up any cancer cells too small to see, lowering the chance the cancer will return later.

After a lumpectomy or mastectomy, for example, there may be no detectable cancer left, yet a few stray cells could remain in the body. Adjuvant therapy targets that possibility. Depending on the type and biology of the cancer, it might take the form of chemotherapy, radiation therapy, hormone-blocking medication such as Tamoxifen, or a targeted drug like Trastuzumab. Often more than one of these is combined, each working in a different way.

The decision about whether adjuvant therapy makes sense, and which kind, depends on many factors unique to you: the size and grade of the tumor, whether lymph nodes were involved, and features like hormone receptor or HER2 status. When treatment is given before the main surgery instead, to shrink a tumor first, it is called neoadjuvant therapy. Your care team can walk you through how these pieces fit together in your specific situation.

Adjuvant therapy is one of the main reasons survival rates for many cancers have improved over the decades. By addressing the cells that imaging and surgery cannot catch, it meaningfully reduces the odds of recurrence for a great many women, turning a one-time treatment into a more complete one.

Understanding what adjuvant therapy is can also help the decisions feel less overwhelming. These choices often involve weighing benefits against side effects, and knowing the goal, lowering future risk, gives you a clearer frame for the conversations ahead about what fits your life and your priorities.